Clinical Trial Update: MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study [NA]

View source ↗

Summary

Post-approval study update for the Flow Re-Direction Endoluminal Device X (FRED X) treating intracranial aneurysm; study status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Aneurysm

Drugs mentioned

• Flow Re-Direction Endoluminal Device X (FRED X)

Snippet

Sponsor: Microvention-Terumo, Inc. | Conditions: Intracranial Aneurysm | NA | Status: ACTIVE_NOT_RECRUITING